The reason why high-dose melphalan followed by autologous stem-cell transplantation produces good response in multiple myeloma

被引：0
|
作者：
Kuroda, Y
Sakai, A
Okikawa, Y
Munemasa, S
Katayama, Y
Takimoto, Y
Okita, H
Kimura, A
机构：
[1] Hiroshima Univ, Res Ins Rad Bio & Med, Dept Hematol & Oncol, Hiroshima 730, Japan
[2] Natl Otake Hosp, Otake, Japan
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：385B / 385B
页数：1
相关论文
共 50 条
  • [41] Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma
    A I Chen
    R S Negrin
    A McMillan
    J A Shizuru
    L J Johnston
    R Lowsky
    D B Miklos
    S Arai
    W-K Weng
    G G Laport
    K Stockerl-Goldstein
    Bone Marrow Transplantation, 2012, 47 : 516 - 521
  • [42] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Miyamoto, Toshihiro
    Yoshimoto, Goichi
    Kamimura, Tomohiko
    Muta, Tsuyoshi
    Takashima, Shuichiro
    Ito, Yoshikiyo
    Shiratsuchi, Motoaki
    Choi, Ilseung
    Kato, Koji
    Takenaka, Katsuto
    Iwasaki, Hiromi
    Takamatsu, Yasushi
    Teshima, Takanori
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (03) : 337 - 345
  • [43] Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma
    Toshihiro Miyamoto
    Goichi Yoshimoto
    Tomohiko Kamimura
    Tsuyoshi Muta
    Shuichiro Takashima
    Yoshikiyo Ito
    Motoaki Shiratsuchi
    Ilseung Choi
    Koji Kato
    Katsuto Takenaka
    Hiromi Iwasaki
    Yasushi Takamatsu
    Takanori Teshima
    Koichi Akashi
    International Journal of Hematology, 2013, 98 : 337 - 345
  • [44] Arsenic trioxide with ascorbic acid and high-dose melphalan for autologous hematopoietic stem cell transplantation for multiple myeloma.
    Qazilbash, Muzaffar H.
    Saliba, Rima M.
    Davis, Marilyn S.
    Mendoza, Floralyn L.
    Hosing, Chitra
    Couriel, Daniel R.
    De Lima, Marcos
    Kebriaei, Partow
    Weber, Donna M.
    Wang, Michael
    Alousi, Arnin M.
    Matthes, Steven G.
    Jones, Roy B.
    Champlin, Richard E.
    Giralt, Sergio A.
    BLOOD, 2006, 108 (11) : 881A - 881A
  • [45] Phagocyte function decreases after high-dose treatment with melphalan and autologous stem cell transplantation in patients with multiple myeloma
    Wichert, Stina
    Pettersson, Asa
    Hellmark, Thomas
    Johansson, Asa
    Hansson, Markus
    EXPERIMENTAL HEMATOLOGY, 2016, 44 (05) : 342 - 351
  • [46] Role of High-Dose Melphalan and Autologous Stem Cell Transplantation in Multiple Myeloma Patients Presenting with t(11;14)
    Sobejano, Eduardo
    De La Calle, Veronica Gonzalez
    Higuero, Victor
    Escalante, Fernando
    Garcia-Sanz, Ramon
    Presa, Daniel
    Azibeiro, Raul
    Fonseca, Marta
    Rey, Beatriz
    Puig, Noemi
    Gutierrez, Norma C.
    Leoz, Pilar
    Labrador, Jorge
    Aguilera, Carmen
    Alonso, Jose Maria Alonso
    Lopez, Rosa
    Mateo, Aranzazu Garcia
    Garcia, Alfonso
    Hernandez, Roberto
    Garcia, Abelardo Barez
    Davila, Julio
    Redondo, Elena
    Quiros, Victor
    Mateos, Maria-Victoria
    BLOOD, 2019, 134
  • [47] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    D Sivaraj
    W Bacon
    G D Long
    D A Rizzieri
    M E Horwitz
    K M Sullivan
    Y Kang
    Z Li
    N J Chao
    C Gasparetto
    Bone Marrow Transplantation, 2018, 53 : 34 - 38
  • [48] Melphalan Dose Intensity for Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma
    Srour, Samer A.
    Milton, Denai
    Bashir, Qaiser
    Mehta, Rohtesh S.
    Delgado, Ruby
    Rondon, Gabriela
    Nieto, Yago
    Hosing, Chitra M.
    Popat, Uday R.
    Ciurea, Stefan O.
    Patel, Krina
    Lee, Hans C.
    Manasanch, Elisabet
    Thomas, Sheeba
    Weber, Donna
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [49] High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma
    Sivaraj, D.
    Bacon, W.
    Long, G. D.
    Rizzieri, D. A.
    Horwitz, M. E.
    Sullivan, K. M.
    Kang, Y.
    Li, Z.
    Chao, N. J.
    Gasparetto, C.
    BONE MARROW TRANSPLANTATION, 2018, 53 (01) : 34 - 38
  • [50] High-dose idarubicine, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma. Comparison with an historical control
    Capria, S
    Ribersani, M
    Ferrazza, G
    Micozzi, A
    Petrucci, MT
    Simone, F
    Torromeo, MC
    Trisolini, SM
    Mandelli, F
    Meloni, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S81 - S82
12345